Navigation Links
Retinal Vein Occlusion Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Date:8/6/2012

Therapeutics Market, Germany, Revenue ($m), 2006- 2011 29

Table 12: Retinal Vein Occlusion Therapeutics Market, Germany, Forecasts ($m), 2011- 2019 30

Table 13: Retinal Vein Occlusion Therapeutics Market, Italy, Revenue ($m), 2006- 2011 31

Table 14: Retinal Vein Occlusion Therapeutics Market, Italy, Forecasts ($m), 2011- 2019 32

Table 15: Retinal Vein Occlusion Therapeutics Market, Spain, Revenue ($m), 2006- 2011 33

Table 16: Retinal Vein Occlusion Therapeutics Market, Spain, Forecasts ($m), 2011- 2019 34

Table 17: Retinal Vein Occlusion Therapeutics Market, The UK, Revenue ($m), 2006- 2011 35

Table 18: Retinal Vein Occlusion Therapeutics Market, The UK, Forecasts ($m), 2011- 2019 36

Table 19: Retinal Vein Occlusion Therapeutics Market, Japan, Revenue ($m), 2006- 2011 37

Table 20: Retinal Vein Occlusion Therapeutics Market, Japan, Forecasts ($m), 2011- 2019 38

Table 21: Lucentis Phase III Clinical Trial Details 43

Table 22: Number (%) of Patients With ? 15 Letter Improvement from Baseline in Best-Corrected Visual Acuity 44

Table 23: Adverse Reactions Reported by >2% of Patients in the First Six Months 44

Table 24: Retinal Vein Occlusion Therapeutics, Phase III Pipeline, 2012 47

Table 25: Retinal Vein Occlusion Therapeutics, Phase II/III Pipeline, 2012 47

Table 26: Retinal Vein Occlusion Therapeutics, Phase II Pipeline, 2012 48

Table 27: Retinal Vein Occlusion Therapeutics, Phase I/II Pipeline, 2012 48

Table 28: RVO Therapeutics - Most Promising Drugs Under Clinical Development, 2012 51

Table 29: Eylea Phase III Clinical Trial Details 53

Table 30: Retinal Vein Occlusion Therapeutics, Clinical Trials by Country, 2012 54

Table 31: Retinal Vein Occlusion Therapeutics, Clinical Trials by Phase, 2012 55

Table 32: Retinal Vein Occlusion Therapeutics, Clinical Trials by Status, 2012 56

Table 33: Retinal Vein Occlusion
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Frost & Sullivan: High Uptake of New Drug Therapies and Aging Population Expansion Keep the U.S. Retinal Therapeutics Market Buoyant
2. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
3. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
4. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
5. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
6. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
7. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
8. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
9. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
10. Zenobia Therapeutics, Inc. And BioBlocks, Inc. Announce Sale Of A Joint Fragment Library Ideal For Screening By All Popular Methods
11. New Forecast Shows Global Protein Therapeutics Market to Reach $143.4 Billion by 2015
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... YORK , May 22, 2013 While ... their teens, friends to drink at home under adult ... about drinking, the truth is that there are serious ... Partnership at Drugfree.org and The Treatment Research ... new, interactive web resource for parents and caregivers to ...
(Date:5/22/2013)... SOUTH SAN FRANCISCO, Calif. , May 22, 2013 ... ) today announced the clinical advancement of three programs ... ophthalmic formulation of a JAK/SYK inhibitor, R348, being developed ... The other two programs are aimed at oncology targets ... AXL kinase inhibitor under development by BerGenBio AS (BerGenBio) ...
(Date:5/22/2013)... , May 22, 2013 Assured Pharmacy, Inc. ... prescription medications to sufferers of chronic pain, announced it ... national investor relations firm, to raise its visibility and ... "Over the past year, we have proven our business ... announced plans to open two additional new pharmacies in ...
Breaking Medicine Technology:Myths Debunked: Underage Drinking of Alcohol at Home Leads to Real Consequences for Both Parents and Teens 2Myths Debunked: Underage Drinking of Alcohol at Home Leads to Real Consequences for Both Parents and Teens 3Myths Debunked: Underage Drinking of Alcohol at Home Leads to Real Consequences for Both Parents and Teens 4Myths Debunked: Underage Drinking of Alcohol at Home Leads to Real Consequences for Both Parents and Teens 5Myths Debunked: Underage Drinking of Alcohol at Home Leads to Real Consequences for Both Parents and Teens 6Myths Debunked: Underage Drinking of Alcohol at Home Leads to Real Consequences for Both Parents and Teens 7Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye 2Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye 3Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye 4Assured Pharmacy Hires Hayden IR 2Assured Pharmacy Hires Hayden IR 3
... Rhythmia Medical Inc., announced today that key results ... be presented at the 2011 Annual Scientific Session ... CA. The results will highlight the performance of ... can significantly improve cardiac ablation procedures by generating ...
... April 27, 2011 Amylin Pharmaceuticals, Inc. (Nasdaq: ... Annual Healthcare Conference on Wednesday, May 4, 2011 ... Mark Foletta, senior vice president, finance and chief financial officer ... The presentation will be webcast live through the "Investors" section ...
Cached Medicine Technology:Rhythmia Medical Highlights Studies to be Presented at Heart Rhythm Society 2011 Annual Scientific Session 2
(Date:5/22/2013)... (HealthDay News) -- Fish oil supplements could help ... research suggests. The supplements, also known ... hormone called adiponectin that,s linked to insulin sensitivity, ... in the bloodstream have also been linked to ... prior animal studies found fish oil increased circulating ...
(Date:5/22/2013)... father,s depression have on his young son or daughter? When ... marriage, their children benefit, said a University of Illinois study. ... need to be able to attend to the child,s emotional ... and notice whether he is getting frustrated or needs help. ... a U of I professor of human development. , But ...
(Date:5/22/2013)... that make energy to keep cells alive is a ... drug-resistant forms of cancer source of a serious ... a new study published in the journal ACS ... explain that doxorubicin and other common forms of chemotherapy ... cancer cells. Cancer cells divide and multiply faster than ...
(Date:5/22/2013)... 22, 2013 Slip and fall hazards ... a number of factors. A December 2010 CDC (Centers ... hazards as the most common: contaminants on the floor, ... conditions, inadequate lighting, and lack of handrails (i). Common ... strained ligaments and muscles, fractures, broken bones, spinal ...
(Date:5/22/2013)... Spinal Elements, an innovative spine ... Carlsbad to 3115 Melrose Drive, Suite 200, Carlsbad, ... continued and projected growth and has expanded the ... to over 40,000 square feet. , Jason ... “Our investment in these state-of-the-art facilities will significantly ...
Breaking Medicine News(10 mins):Health News:Fish Oil Pills Might Cut Diabetes Risk, Researchers Say 2Health News:Good marriage can buffer effects of dad's depression on young children 2Health News:Law Firm Releases Slip and Fall Accident Informational Graphic to Show the Frequency and Cost of These Incidents 2Health News:Law Firm Releases Slip and Fall Accident Informational Graphic to Show the Frequency and Cost of These Incidents 3Health News:Spinal Elements®, Inc. Relocates Corporate Headquarters in Carlsbad 2
... networks in fruit flies has led researchers to a sensitive ... most common type of kidney cancer. In the journal ... at the University of Chicago shows that the biomarker known ... renal cell carcinomas but not by normal kidney tissue. , ...
... new 30" in groundbreaking new calendarHAGATNA, Guam, Jan. 27 ... natural calendar to promote her "Look Good Naked" theme ... is beautifully captured au natural and semi-nude in high-quality ... in her beautiful cottage home. "I wanted to show ...
... HCA Healthcare announces the following Webcast:, What: ... 10:00 EST, Where: http://www.videonewswire.com/event.asp?id=55052 , How: ... web at the, ... +1-615 344 ...
... Jan. 27 /PRNewswire-FirstCall/ - QLT Inc. ("QLT") (NASDAQ: ... modified "Dutch Auction" tender offer (the "Offer"), which expired at ... on the preliminary report of the depository for the Offer, ... shares (the "Shares") at a price of US$2.50 per Share, ...
... -- The University of Texas at San Antonio (UTSA) ... College of Engineering has been awarded a $199,884, 24-month ... energy combustion. , "This is one of the first ... combustion, gasification and energy efficiency," said Efstathios Michaelides, mechanical ...
... adds affordable, professionally refurbished Hill-Rom hospital beds to its ... ... -- DRE Medical Equipment — named by Business First of Louisville ... refurbished Hill-Rom hospital beds . DRE’s extensive lineup of economically-priced ...
Cached Medicine News:Health News:Roadkill study could speed detection of kidney cancer 2Health News:QLT announces preliminary results of tender offer 2Health News:QLT announces preliminary results of tender offer 3Health News:UTSA receives federal funding for fossil fuel research 2Health News:DRE Medical Equipment Now Sells Reconditioned Hill-Rom Hospital Beds 2Health News:DRE Medical Equipment Now Sells Reconditioned Hill-Rom Hospital Beds 3
Calcium Chloride 0.020M - 4 ml...
Plasma Control Level 2 - 1 ml...
... CELL-DYN 3200 sets a benchmark of ... scatter for WBC, RBC, PLT and ... the needs of today's laboratory. The ... differential analysis, automated sample handling, comprehensive ...
Provides the security of braided polyester suture and ease of an automated knot for vascular closure of 5-8Fr....
Medicine Products: